Mental health advocates are lobbying Congress to help them get schizophrenia classified as a brain disease like Parkinson or Alzheimer disease, instead of as a mental illness; the annual Consumer Electronics Show, which begins this week in Las Vegas, has become an increasingly popular place for health technology firms looking for publicity in the $7 trillion global medical industry; the Trump administration warned scientists doing biomedical research at American universities that Chinese spies may be trying to steal and exploit information.
Mental health advocates are lobbying Congress to help them get schizophrenia classified as a brain disease like Parkinson or Alzheimer disease, instead of as a mental illness, Politico reported. The Schizophrenia and Related Disorders Alliance of America is among those pushing Congress to include schizophrenia in a new CDC program that aims to collect data on the prevalence and risk factors of neurological conditions in the United States, a move that could reduce stigma and lead to more funding for a cure. The problem is that the CDC only has enough money to study a finite number of conditions, putting disease advocacy groups in competition with each other.
The annual Consumer Electronics Show, which begins this week in Las Vegas, has become an increasingly popular place for health technology firms looking for publicity in the $7 trillion global medical industry, STAT News reported. This year brings a particular focus on chronic disease, but some experts warn that the real-world results of digital health products have not caught up to their promises. Companies will feature products targeting heart monitoring, diabetes, and nonopioid management of chronic pain.
The Trump administration warned scientists doing biomedical research at American universities that Chinese spies may be trying to steal and exploit information, The New York Times reported. Scientists and universities receiving National Institutes of Health funding need to tighten their security procedures and take other precautions, said a panel of experts commissioned by the agency to investigate “foreign influences on research integrity.”
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Insurance Coverage Limits JAKi Therapy Access for Patients With AA, Especially Non-White Populations
April 25th 2024A survey study showed major barriers to Janus kinase inhibitor (JAKi) therapy for patients with alopecia areata, especially for non-White patients who face higher rates of being uninsured and struggle more to afford the treatment.
Read More